Compare OVID & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | TLRY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.9M | 533.5M |
| IPO Year | 2017 | 2018 |
| Metric | OVID | TLRY |
|---|---|---|
| Price | $2.56 | $2.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $6.40 | $5.72 |
| AVG Volume (30 Days) | 2.4M | ★ 4.2M |
| Earning Date | 11-10-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.90 | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | $20.44 |
| Revenue Next Year | N/A | $5.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.18 | $0.77 |
| 52 Week High | $3.11 | $15.70 |
| Indicator | OVID | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 32.01 |
| Support Level | $2.12 | $2.49 |
| Resistance Level | $2.67 | $3.00 |
| Average True Range (ATR) | 0.24 | 0.15 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 44.95 | 4.76 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.